Bilaketaren emaitzak - Hitomi Hosoya
- Erakusten 1 - 9 emaitzak -- 9
-
1
Self-targeting of TNF-releasing cancer cells in preclinical models of primary and metastatic tumors nork Eleonora Dondossola, Andrey S. Dobroff, Serena Marchiò, Marina Cardó‐Vila, Hitomi Hosoya, Steven K. Libutti, Angelo Corti, Richard L. Sidman, Wadih Arap, Renata Pasqualini
Argitaratua 2016Artigo -
2
Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma nork Surbhi Sidana, Hitomi Hosoya, Alexandria Jensen, Lawrence Liu, Anmol Goyal, Vanna Hovanky, Bita Sahaf, Sushma Bharadwaj, Theresa Latchford, Sally Arai, Sheryl Leahy, Matthew Mei, Lihua E. Budde, Lori Muffly, Matthew J. Frank, Saurabh Dahiya, Myo Htut, David B. Miklos, Murali Janakiram
Argitaratua 2023Carta -
3
Deciphering response dynamics and treatment resistance from circulating tumor DNA after CAR T-cells in multiple myeloma nork Hitomi Hosoya, Mia Carleton, Kailee Tanaka, Brian J. Sworder, Shriya Syal, Bita Sahaf, Alisha M. Birk, Oscar Silva, Henning Stehr, Vanna Hovanky, George E. Durán, Tian Zhang, Michaela Liedtke, Sally Arai, David Iberri, David B. Miklos, Michael S. Khodadoust, Surbhi Sidana, David M. Kurtz
Argitaratua 2025Artigo -
4
Combinatorial targeting and discovery of ligand-receptors in organelles of mammalian cells nork Roberto Rangel, Liliana Guzman‐Rojas, Lucia Le Roux, Fernanda I. Staquicini, Hitomi Hosoya, E. Magda Barbu, Michael G. Ozawa, Jing Nie, Kenneth Dunner, Robert R. Langley, E. Helene Sage, Erkki Koivunen, Juri G. Gelovani, Roy R. Lobb, Richard L. Sidman, Renata Pasqualini, Wadih Arap
Argitaratua 2012Artigo -
5
PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA <i>PCA3</i> nork Ahmad Salameh, Alessandro K. Lee, Marina Cardó‐Vila, Diana Noronha Nunes, Eleni Efstathiou, Fernanda I. Staquicini, Andrey S. Dobroff, Serena Marchiò, Nora M. Navone, Hitomi Hosoya, Richard C. Lauer, Sijin Wen, Carolina C. Salmeron, Anh Hoang, Irene Newsham, Leandro A. Lima, Dirce Maria Carraro, Salvatore Oliviero, Mikhail G. Kolonin, Richard L. Sidman, Kim‐Anh Do, Patricia Troncoso, Christopher J. Logothetis, Helena Brentani, George A. Călin, Webster K. Cavenee, Emmanuel Dias‐Neto, Renata Pasqualini, Wadih Arap
Argitaratua 2015Artigo -
6
Idecabtagene vicleucel chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma with renal impairment nork Surbhi Sidana, Lauren C. Peres, Hamza Hashmi, Hitomi Hosoya, Christopher Ferreri, Jack Khouri, Danai Dima, Shebli Atrash, Peter M. Voorhees, Gary Simmons, Douglas W. Sborov, Nilesh Kalariya, Vanna Hovanky, Sushma Bharadwaj, David B. Miklos, Charlotte Wagner, Mehmet H. Kocoglu, Gurbakhash Kaur, James A. Davis, Shonali Midha, Murali Janakiram, Ciara L. Freeman, Melissa Alsina, Frederick L. Locke, Rebecca Gonzalez, Yi Lin, Joseph P. McGuirk, Aimaz Afrough, Leyla Shune, Krina K. Patel, Doris K. Hansen
Argitaratua 2023Artigo -
7
Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma nork Jennifer M. Logue, Lauren C. Peres, Hamza Hashmi, Christelle Colin, Alexandria M Shrewsbury, Hitomi Hosoya, Rebecca Gonzalez, Christina Copponex, Krista H. Kottra, Vanna Hovanky, Bita Sahaf, Sunita Patil, Aleksandr Lazaryan, Michael D. Jain, Aliyah Baluch, Olga Klinkova, Nelli Bejanyan, Rawan Faramand, Hany Elmariah, Farhad Khimani, Marco L. Davila, Asmita Mishra, Brandon Blue, Ariel Grajales‐Cruz, Omar Castañeda Puglianini, Hien Liu, Taiga Nishihori, Ciara L. Freeman, Jason Brayer, Kenneth H. Shain, Rachid Baz, Frederick L. Locke, Melissa Alsina, Surbhi Sidana, Doris K. Hansen
Argitaratua 2022Artigo -
8
A Phase 1 Clinical Trial of NKTR-255 with CD19-22 CAR-T Cell Therapy for Refractory B-cell Acute Lymphoblastic Leukemia nork Hrishikesh K. Srinagesh, Clayton Jackson, Parveen Shiraz, Nikeshan Jeyakumar, Mark Hamilton, Emily Egeler, Sharon Mavroukakis, Adam Kuo, Juancarlos Cancilla, Bita Sahaf, Neha Agarwal, Alyssa M. Kanegai, Anne Marijn Kramer, Sally Arai, Sushma Bharadwaj, Saurabh Dahiya, Hitomi Hosoya, Laura Johnston, Vanessa E. Kennedy, Michaela Liedtke, Robert Lowsky, Lekha Mikkilineni, Robert S. Negrin, Andrew R. Rezvani, Surbhi Sidana, Judith A. Shizuru, Melody Smith, Wen‐Kai Weng, Steven A. Feldman, Matthew J. Frank, Zachary Lee, Mary Tagliaferri, A Mario Q. Marcondes, David B. Miklos, Crystal L. Mackall, Lori Muffly
Argitaratua 2024Artigo -
9
Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas nork Brian J. Sworder, David M. Kurtz, Stefan Alig, Matthew J. Frank, Navika Shukla, Andrea Garofalo, Charles Macaulay, Mohammad Shahrokh Esfahani, Mari Olsen, James N. Hamilton, Hitomi Hosoya, Mark Hamilton, Jay Y. Spiegel, John H. Baird, Takeshi Sugio, Mia Carleton, Alexander Craig, Sheren Younes, Bita Sahaf, Natasha D. Sheybani, Joseph G. Schroers‐Martin, Chih Long Liu, Jean Oak, Michael C. Jin, Sara Beygi, Andreas Hüttmann, Christine Hanoun, Ulrich Dührsen, Jason R. Westin, Michael S. Khodadoust, Yasodha Natkunam, Robbie G. Majzner, Crystal L. Mackall, Maximilian Diehn, David B. Miklos, Ash A. Alizadeh
Argitaratua 2022Artigo
Bilaketa egiteko lanabesak:
Antzeko gaiak
Biology
Medicine
Cancer research
Immunology
Internal medicine
Multiple myeloma
Astrobiology
Cancer
Computational biology
Genetics
Oncology
Physics
Refractory (planetary science)
CD19
Chemotherapy
Chimeric antigen receptor
Gene
Leukemia
Acoustics
Acute lymphocytic leukemia
Anemia
Antibody
Antigen
Astronomy
B cell
Bendamustine
Biochemistry
Bioinformatics
Bone marrow
Cell